అకౌంట్స్ గమనికలుOnEMI Technology Solutions Ltd.

Mar 31, 2026

2.17 Provisions & Contingencies
Provisions:

The Company recognises a provision when
there is a present obligation as a result of past
events, it is probable that an outflow of resources
embodying economic benefits will be required to
settle the obligation and a reliable estimate of the
amount of the obligation can be made. The amount
recognised as a provision is the best estimate of
the consideration required to settle the present
obligation at the end of the reporting period, taking
into account the risk and uncertainties surrounding
the obligation.

The cases where the available information
indicates that the loss on the contingency is the
reasonably estimated, a disclosure is made in the
financial statements. Provisions are reviewed at
each balance sheet date and adjusted to reflect the
current best estimates. If it is no longer probable
that the outflow of resources would be required to
settle the obligation, the provision is reversed.

Contingencies:

Contingent liabilities are disclosed when there
is a possible obligation arising from past events,
the existence of which will be confirmed only by
the occurrence or non occurrence of one or more
uncertain future events not wholly within the control
of the past events but probably will not require an
outflow of resources to settle the obligation.

When there is a possible obligation or a present
obligation in respect of which likelihood of outflow
of resources is remote, no provision or disclosure
is made.

Contingent assets are neither recognised nor
disclosed in the financial statements.

2.18 Shares based payments for Services Rendered

The Company accounts for share-based payments
in accordance with Ind AS 102 - Share-based
payments. When equity shares are issued to
non-employees in exchange for services, the
transaction is treated as a share-based payment.
The fair value of the services received is recognized
as an expense in the Statement of Profit and Loss,
with a corresponding increase in equity.

2.19 Segment Reporting

The Company is primarily engaged in the business
of providing financial technology solutions to
enable use of instant EMI / instalment solutions
to consumers, and in providing the technology
platform to enable the above. Accordingly, the
Company is engaged in only one business segment
and primarily in one geographical segment.
Therefore, these financial statements pertain to
one business segment.

2.20 Earning Per Share

The Company reports basic and diluted earnings
per share in accordance with Ind AS 33 on Earnings
per share. Basic EPS is calculated by dividing the
net profit or loss for the year attributable to equity
shareholders (after deducting preference dividend
and attributable taxes) by the weighted average
number of equity shares outstanding during
the year. For the purpose of calculating diluted
earnings per share, the net profit or loss for the
year attributable to equity shareholders and the
weighted average number of shares outstanding
during the year are adjusted for the effects of all
dilutive potential equity shares.

In computing the dilutive earnings per share, only
potential equity shares that are dilutive and that
either reduce the earnings per share or increases
loss per share are included.

2.21 Statement of cash flow

Cash flows are reported under the ''Indirect method''
as set out in Ind AS 7 on ''Statement of Cash Flows,
whereby net profit after tax is adjusted for the
effects of transactions of non-cash nature, tax
and any deferrals or accruals of past or future cash
receipts or payments. The cash flows are prepared
for the operating, investing and financing activities
of the Company.

3.1 Judgements

The preparation of the financial statements in
conformity with Ind AS requires management
to make estimates and assumptions considered
in the reported amounts of assets and liabilities
(including contingent liabilities) and the reported
income and expenses during the year. Estimates
and underlying assumptions are reviewed on an
ongoing basis. Revisions to accounting estimates
are recognised prospectively.

3.2 Estimates and Assumptions

The key assumptions concerning the future and
other key sources of estimation uncertainty at
the reporting date, that have a significant risk
of causing a material adjustment to the carrying
amounts of assets and liabilities within the next
financial year, are described below. The Company
based its assumptions and estimates on parameters
available when the financial statements were
prepared. Existing circumstances and assumptions
about future developments, however, may change
due to market changes or circumstances arising
that are beyond the control of the Company. Such
changes are reflected in the assumptions when
they occur.

Following are the areas that involved a higher
degree of estimates and judgement or complexity
in determining the carrying amount of some assets
and liabilities.

(i) Fair value of financial instruments

The fair value of financial instruments is the price
that would be received to sell an asset or paid
to transfer a liability in an orderly transaction in
the principal (or most advantageous in absence
of principal market) market at the measurement
date under current market conditions (i.e. an exit
price) regardless of whether that price is directly
observable or estimated using another valuation
technique. When the fair values of financial assets
and financial liabilities recorded in the balance
sheet cannot be derived from active markets,
they are determined using a variety of valuation
techniques that include the use of valuation
models. The inputs to these models are taken from
observable markets where possible, but where this

is not feasible, estimation is required in establishing
fair values.

(ii) Impairment of financial asset

The company has created the expected credit
loss provision against trade receivables. Given
the subjectivity and uncertainty of determining
the probability and amount of losses, the
Company takes into account a number of factors
including historical data, business forecast etc.
Significant judgment is required to conclude on
these estimates.

(iii) Contingent liabilities and provisions other than
impairment on loan portfolio

Provisions and liabilities are recognised in the
period when it becomes probable that there will
be a future outflow of funds resulting from past
operations or events and the amount of cash
outflow can be reliably estimated. The timing
of recognition and quantification of the liability
requires the application of judgement to existing
facts and circumstances, which can be subject
to change. The carrying amounts of provisions
and liabilities are reviewed at each Balance sheet
date and revised to take account of changing facts
and circumstances.

(iv) Leases

Ind AS 116 "Leases" requires lessee to determine
the lease term as the non-cancellable period of a
lease adjusted with any option to extend or terminate
the lease, if the use of such option is reasonably
certain. The Company makes assessment on the
expected lease term on lease by lease basis and
thereby assesses whether it is reasonably certain
that any options to extend or terminate the contract
will be exercised. In evaluating the lease term, the
Company considers factors such as any significant
leasehold improvements undertaken over the lease
term, costs relating to the termination of lease and
the importance of the underlying to the Company''s
operations taking into account the location of the
underlying asset and the availability of the suitable
alternatives. The lease term in future periods is
reassessed to ensure that the lease term reflects
the current economic circumstances.

(v) Defined employee benefit assets and liabilities

The cost of the defined benefit gratuity plan and
the present value of the gratuity obligation are

determined using actuarial valuations. An actuarial
valuation involves making various assumptions that
may differ from actual developments in the future.
These include the determination of the discount
rate; future salary increases and mortality rates.
Due to the complexities involved in the valuation and
its long-term nature, a defined benefit obligation is
highly sensitive to changes in these assumptions.
All assumptions are reviewed annually.

(vi) Fair value of share-based payment

The Company accounts for share-based payment
transactions in accordance with Ind AS 102 -
Share-based payment.

Equity-settled share-based payments to
employees and others providing services are
measured at the fair value of the equity instruments
granted at the grant date. The fair value determined
at the grant date is recognised as an expense
over the vesting period, based on the Company''s
estimate of the number of equity instruments that
will eventually vest, with a corresponding increase
in equity.

The fair value of options granted is determined
using an appropriate option pricing model (e.g.,
Black-Scholes or Binomial model), considering

the terms and conditions upon which the options
were granted. The model takes into account inputs
such as:

â¢ Share price at the grant date

â¢ Exercise price of the option

â¢ Expected volatility

â¢ Expected life of the option

â¢ Expected dividends

â¢ Risk-free interest rate

Estimates of vesting conditions (other than market
conditions) are revised at each reporting date. The
impact of the revision of original estimates, if any, is
recognised in the Statement of Profit and Loss with
a corresponding adjustment to equity.

(vii) Recognition of deferred tax assets

The Company has recognized deferred tax assets
and concluded that the deferred tax assets will
be recoverable using the estimated future taxable
income based on the experience and future
projections. The Company is expected to generate
adequate taxable income for liquidating these
assets in due course of time.

14.2 Terms/rights attached to shares
14.2.1 Equity shares

The Company has issued only one class of equity shares having a par value of ?1 per share(pursuant to the split of shares of
the Company approved in the Board of Directors meeting held on July 8, 2025). Each holder of equity shares is entitled to one
vote per share. Any dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing
annual general meeting. The Company has not declared/proposed any dividend in the current year and previous year.

During the financial year ended 31 March 2026, the Company converted certain Compulsorily Convertible Preference
Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the Board of
Directors and shareholders.

Series A CCPS aggregating to 7,86,684 CCPS were converted into equity shares during the year.

Series B CCPS aggregating to 4,88,263 CCPS were converted into equity shares during the year.

Series C CCPS aggregating to 16,29,078 CCPS were converted into equity shares during the year.

Series D1 CCPS aggregating to 7,03,903 CCPS were converted into equity shares during the year.

Series E CCPS aggregating to 16,70,167 CCPS were converted into equity shares during the year.

Series E1 CCPS aggregating to 1,19,416 CCPS were converted into equity shares during the year.

Series Z1 CCPS aggregating to 31,797 CCPS were converted into equity shares during the year.

Series Z2 CCPS aggregating to 25,068 CCPS were converted into equity shares during the year.

Series Z3 CCPS aggregating to 22,301 CCPS were converted into equity shares during the year.

Series Z4 CCPS aggregating to 53,778 CCPS were converted into equity shares during the year.

Consequent to the above conversions, the corresponding CCPS balances stand extinguished/reduced and the paid-
up equity share capital of the Company increased by issuance of equity shares as per the applicable conversion ratio
prescribed in the respective agreements.

During the previous year the Company has converted 2 Series A OCRPS having face value of ?100 each into 2,91,456
Equity Shares having face value of ?10 each in the ratio 1: 1,45,728 and 2 Series B OCRPS having face value of ?100
each into 2,91,256 Equity Shares having face value of ?10 each in the ratio 1: 1,45,728.

In the event of liquidation of the Company, the holders of equity shares will be entitled to receive any of the remaining
assets of the Company in proportion to the number of equity shares held by the shareholders, after distribution of all
preferential amounts.

As per records of the Company, including its register of shareholder/members and other declaration received from
shareholders regarding beneficial interest, the above share holding represents both legal and beneficial ownerships
of shares.

14.2.2 Preference shares

a) Terms/rights attached to Series A CCPS

The Company has issued 0.10% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face
value ?10 per share aggregating to ?78,66,840 which are convertible into equity shares at any time before expiry
of 19 years from the date of issuance with conversion ratio of 1:9.29025084745763 (to account for such sub-
division)[Previous year: 1:0.929025084745763].

The preference shareholders have a right to receive dividend prior to equity shareholders. The dividend proposed
by the Board of Directors on the preference shares is subject to the approval of the shareholders at the ensuing
Annual General Meeting, except in the case of interim dividend.

In the event of liquidation, the Preference Shareholders are eligible to receive the remaining assets of the
Company before distribution to the equity shareholders, in proportion to their shareholding.

In the event of liquidation, the holders of Series A CCPS shall have preference over the other Shareholders of
the Company other than holders of Series E CCPS, Secondary Shares, Series D1 CCPS and Series C CCPS and
Series B CCPS for return of capital invested towards the subscription of Series A CCPS.

During the financial year ended 31 March 2026, the Company converted 7,86,684 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

b) Terms/rights attached to Series B CCPS

The Company has issued 0.10% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face
value ?10 per share aggregating to ?48,82,630 which are convertible into equity shares at any time before expiry
of 19 years from the date of issuance with conversion ratio of 1:10(to account for such sub-division)[Previous
year: 1:1].

In the event of liquidation, The holders of Series B CCPS shall have preference over the other Shareholders of
the Company other than holders of Series E CCPS, Secondary Shares, Series D1 CCPS and Series C CCPS (but
including holders of Series A CCPS) for return of capital invested towards the subscription of Series B CCPS.

During the financial year ended 31 March 2026, the Company converted 4,88,263 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

c) Terms/rights attached to Series C CCPS

The Company has issued 0.0001% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face value
?10 per share aggregating to ?1,62,90,780 which are convertible into equity shares at any time before expiry of 19
years from the date of issuance with conversion ratio of l:l0(to account for such sub-division)[Previous year: 1:1].

In the event of liquidation, The holders of Series C CCPS shall have preference over all the other Shareholders of
the Company other than holders of Series E CCPS, Secondary Shares and Series D1 CCPS (but including holders
of Series A CCPS and Series B CCPS) for return of capital invested towards the subscription of Series C CCPS.

During the financial year ended 31 March 2026, the Company converted 16,29,078 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

d) Terms/rights attached to Series D1 CCPS

The Company has issued 0.0001% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face value
?10 per share aggregating to ?70,39,030 which are convertible into equity shares at any time before expiry of 19
years from the date of issuance with conversion ratio of 1:10(to account for such sub-division)[Previous year: 1:1].

In the event of liquidation, The holders of Series D1 CCPS shall have preference over all the other Shareholders of
the Company other than holders of Series E CCPS and Secondary Shares (but including holders of Series A CCPS,
Series B CCPS and Series C CCPS) for return of capital invested towards the subscription of Series D1 CCPS.

During the financial year ended 31 March 2026, the Company converted 7,03,903 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

e) Terms/rights attached to Series E CCPS

The Company has issued 0.0001% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face value
?10 per share aggregating to ?16,701,670 which are convertible into equity shares at any time before expiry of 19
years from the date of issuance with conversion ratio of 1:10(to account for such sub-division)[Previous year: 1:1].

In the event of liquidation, The holders of Series E CCPS and Secondary Shares ("Series E Transaction CCPS")
shall have preference over all the other Shareholders of the Company (including holders of Series A CCPS, Series
B CCPS, Series C CCPS and Series D1 CCPS) for return of capital invested towards: (a) the subscription of Series
E CCPS and (b) acquisition of Secondary Shares.

During the financial year ended 31 March 2026, the Company converted 16,70,167 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

f) Terms/rights attached to Series A OCRPS

The Company has issued 0.01% Optionally Convertible Redeemable Preference shares ("OCRPS") of face value
?100 per share aggregating to ?200 which are convertible into equity shares subject to primary conditions
mentioned in SHA. The tenure of the Series shall be 20 years.

During the year 2024-25, the Company has converted 2 Series A OCRPS having face value of ?100 each into

2.91.456 Equity Shares having face value of ?10 each in the ratio 1: 1,45,728.

g) Terms/rights attached to Series B OCRPS

During the year 2024-25, the Company has converted 2 Series B OCRPS having face value of ?100 each into

2.91.456 Equity Shares having face value of ?10 each in the ratio 1: 1,45,728.

h) Terms/rights attached to Series E1 CCPS

The Company has issued 0.01% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face
value ?100 per share, as fully paid in current year (Previous year: ?1 partly paid) aggregating to ?1,19,416 which
are convertible into equity shares after expiry of 19 years from the date of issuance having conversion ratio of
1:89.78696322 (to account for such sub-division) [Previous year: 1:10].

The holder of each Series E1 CCPS shall be entitled to preferential dividend at the rate of 0.01% per annum on the
face value of the Series E1 CCPS issued. The dividends are non-cumulative in nature and will be payable as and
when declared by the Board of Directors of the Company and/or the shareholders of the Company.

During the financial year ended 31 March 2026, the Company converted 1,19,416 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

i) Terms/rights attached to Series Z1 CCPS

The Company has issued 0.0001% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face
value ?10 per share, as fully paid in current year (Previous year: ?1 partly paid) aggregating to ?31,797 which are
convertible into equity shares after expiry of 19 years from the date of issuance with conversion ratio of 1:10(to
account for such sub-division)[Previous year: 1:1].

Series Z1 CCPS shall be entitled to a cumulative dividend as given to holder of the Preference Shares in the
Series E Equity round in preference of Equity Shares. Dividend shall be paid as and when it is paid and declared
on Equity Shares.

In the event of liquidation, The holders of Series Z1 CCPS shall have liquidation preference as available to the
investors of Series E Equity Round in the company on a pari passu basis.

During the financial year ended 31 March 2026, the Company converted 31,797 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

j) Terms/rights attached to Series Z2 CCPS

The Company has issued Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face value
?10 per share, as fully paid in current year (Previous year: ?1 partly paid) aggregating to ?25.068 which are
convertible into equity shares which are convertible into equity shares after expiry of 19 years from the date of
issuance with conversion ratio of 1:10(to account for such sub-division)[Previous year: 1:1].

Series Z2 CCPS shall be entitled to a cumulative dividend as given to holder of the Preference shares in the Series
F Equity round in preference of Equity Shares. Dividend shall be paid as and when it is paid and declared on
Equity Shares.

In the event of liquidation, The holders of Series Z2 CCPS shall have liquidation preference as available to the
investors of Series F Equity Round in the company on a pari passu basis.

During the financial year ended 31 March 2026, the Company converted 25,068 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

k) Terms/rights attached to Series Z3 CCPS

The Company has issued 0.001% Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face
value ?10 per share, as fully paid in current (Previous year: ?1 partly paid) aggregating to ?22.301 which are
convertible into equity shares after expiry of 8 years from the date of issuance which are convertible into equity
shares after expiry of 19 years from the date of issuance with conversion ratio of l:l0(to account for such sub-
division)[Previous year: 1:1].

The Series Z3 CCPS are cumulative, participating, compulsorily and fully convertible preference shares having
a face value of ?10 each. Minimum preferential cumulative dividend rate is 0.001% of the face value per annum
pari passu with the preferential dividend payable to any other holder of preference shares. In addition to and
after payment of the Investor Preferential Dividend, holders of Series Z3 CCPS would be entitled to participate
pari passu in any cash or non-cash dividends paid to the holders of shares of all other classes (including Equity
Shares) or series on a pro rata, as-if converted basis to the fullest extent permissible under applicable Law.

In the event of a Liquidity Event, Series Z3 CCPS shall have liquidation preference as available to the holders of
Preference Shares in the Subsequent Round.

During the financial year ended 31 March 2026, the Company converted 22,301 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

l) Terms/rights attached to Series Z4 CCPS

The Company has issued Compulsorily Convertible Cumulative Preference shares ("CCCPS") of face value ?10
per share fully paid up aggregating to ?5,37,780 which are convertible into equity shares after expiry of 19 years
from the date of issuance with conversion ratio of 1:10(to account for such sub-division)[Previous year: 1:1].

The Series Z4 CCPS shall carry a predetermined cumulative dividend rate of 0.0001% per annum. Series Z4
CCPS shall be entitled to the same Liquidation Preference as Series E CCPS during a Liquidation Event.

During the financial year ended 31 March 2026, the Company converted 53,778 Compulsorily Convertible
Preference Shares ("CCPS") into Equity Shares in accordance with the respective terms of issue approved by the
Board of Directors and shareholders.

Nature and purpose of the reserves

1. Securities premium

Securities premium reserve is used to record the premium on issue of shares. The reserve can be utilised only
for limited purposes such as issuance of bonus shares in accordance with the provisions of the Companies
Act, 2013.

2. Share based payment reserve

The share-based payment reserve is used to recognise the value of equity-settled share-based payments
provided to employees. Refer to Note 38 for further details of these plans.

3. Capital redemption reserve

The Company has recognised capital redemption reserve on conversion of cumulative compulsory convertible
preference shares (CCPS) into Equity Shares.

4. Retained earnings

Retained earnings represent the amount of accumulated earnings of the Company.

Terms/rights attached to Series Z1 OCRPS

The Company has issued 0.001% Optionally Convertible Redeemable Preference shares ("OCRPS") of face value ?10
per share, as fully paid in current year (Previous year: ?1 partly paid) aggregating to ?45,021 which are convertible
into equity shares upon happening of the following two events with conversion ratio of 1:1.

i. at the election of the Series holder; or

ii. upon the occurrence of a Liquidity Event.(expiry after 8 years)

The Series Z1 OCRPS have been converted into equity shares at a conversion ratio of 1:10 pursuant to the option
exercised by the Series Z1 OCRPS holder and pursuant to the split of shares of the Company approved in the Board of
Directors meeting held on July 8, 2025.

The ultimate parent entity and its subsidiary are incorporated in India. Based on the assessment performed, the
consolidated revenue of the Group does not exceed the threshold of EUR 750 million prescribed under the OECD
Pillar Two Global Anti-Base Erosion (GloBE) Rules. Accordingly, the Group is not within the scope of such rules and no
material Pillar Two tax exposure has been identified as at the reporting date.

Note 27 - Earnings per share

Basic EPS is calculated by dividing the profit for the year attributable to equity holders of the Company by the weighted
average number of equity shares outstanding during the year.

Diluted EPS is calculated by dividing the profit attributable to equity holders of the Company by the weighted average
number of equity shares outstanding during the year plus the weighted average number of equity shares that would
be issued on conversion of all the dilutive potential equity shares into equity shares of the Company.

Note 29 - Employee benefit obligations

a) Defined Contribution Plan

The Company makes contributions, determined as a specified percentage of employee salaries, in respect
of qualifying employees towards provident fund and other funds which are defined contribution plans. The
Company has no obligations other than this to make the specified contributions. The contributions are charged to
the Statement of Profit and Loss as they accrue. The Company makes Provident Fund, Employee State Insurance
Scheme and Maharashtra Labour Welfare Fund contributions which are defined contribution plans for qualifying
employees. Under the Schemes, the Company is required to contribute a specified percentage of the payroll
costs to fund the benefits. The Company recognized ?9.72 million (31 March 2025: ?12.28 million) for Provident
Fund contributions, Employee State Insurance Scheme and Maharashtra Labour Welfare Fund. The contributions
payable to these plans by the Company are at rates specified in the rules of the Schemes.

b) Defined benefit plans

The Company has a unfunded defined benefit gratuity plan in India. The company''s defined benefit gratuity plan
is a final salary plan for India employees, which requires contributions to be made to a separately administered
fund. The gratuity plan is governed by the Payment of Gratuity Act, 1972 and new Labour codes. The level of
benefits provided depends on the member''s length of service and salary at retirement age.

The following tables summarise the components of net benefit expense recognised in the statement of profit or
loss and the funded status and amounts recognised in the balance sheet for the respective plans:

Note 31 - Capital management

The primary objectives of the Company''s capital management policy are to ensure that the Company complies with
externally imposed capital requirements and maintains strong credit ratings and healthy capital ratios in order to
support its business and to maximise shareholder value.

The Company manages its capital structure and makes adjustments to it according to changes in economic conditions
and the risk characteristics of its activities. In order to maintain or adjust the capital structure, the Company may
adjust the amount of dividend payment to shareholders, return capital to shareholders or issue capital securities. No
changes have been made to the objectives, policies and processes from the previous years. However, they are under
constant review by the Board.

Notes:

1) Directors Sitting fees and Commission includes ?1.00 million Sitting fees paid to Independent directors related
to the public issue of equity shares. This amount has been included under Note 13: Deferred Expenses in Other
Non-Current Assets.

2) During the year ended 31 March 2026, the company has given corporate guarantee for loans sanctioned to
subsidiary company of ?24,389.11 million (Previous year: ?13,134.84 million).

3) Transactions shown above are excluding GST, if any.

4) Managerial Remuneration excludes provision for gratuity and compensated absences, since it is provided on
actuarial basis for the company as a whole and includes director sitting fees and commission.

5) Transactions with related parties are carried out in the normal course of business and at standard market rates on
an arm''s length basis.

6) During the financial year, there were no transactions entered into by the Company with any entity in which the Key
Management Personnel (KMP) or their relatives exercised significant influence.

7) The Company has not engaged in any transactions with the relatives of its KMP during the financial year.

8) The Company has not engaged in any transactions pertaining to loans, advances or investments with companies
in which the director''s have a vested interest. Hence, the disclosure pursuant to Schedule V of Clause A.2 of
Regulation 34 (3) and Regulation 53(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 are not applicable to the company.

Valuation Principle

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction in the
principal (or most advantageous) market at the measurement date under current market conditions (i.e., an exit price),
regardless of whether that price is directly observable or estimated using a valuation technique.

Fair value Hierarchy

This section explains the judgments and estimates made in determining the fair value of the financial instrument
that are (a) recognized and measured at fair value and (b) measured at amortised cost and for which fair values are
disclosed in the financial statements. To provide an indication about the reliability of the inputs used in determining
fair value, the Company has classified its financial instruments into three levels prescribed under the accounting
standard. The Company uses the following hierarchy for determining and disclosing the fair value of the financial
instruments by valuation techniques:

Level 1: Level 1 hierarchy includes financial instruments measured using unadjusted quoted prices in active markets
that the Company has the ability to access for the identical assets or liabilities. A financial instrument is classified as a
Level 1 measurement if it is listed on an exchange.

Level 2: The fair value of financial instruments that are not traded in active markets is determined using valuation
techniques which maximize the use of observable market data either directly or indirectly, such as quoted prices
for similar assets and liabilities in active markets, for substantially the full term of the financial instrument but do not
qualify as Level 1 inputs. If all significant inputs required to fair value an instrument are observable the instrument is
included in level 2.

Level 3: If one or more of the significant inputs is not based in observable market data, the instruments is included in
level 3. That is, Level 3 inputs incorporate market participants'' assumptions about risk and the risk premium required
by market participants in order to bear that risk. The Company develops Level 3 inputs based on the best information
available in the circumstances.

Financial instruments valued at carrying value

The respective carrying values of certain on-balance sheet financial instruments approximated their fair value. These
financial instruments include cash in hand, balances with Banks, financial institutions, accrued interest receivable,
accrued interest payable, and certain other assets and liabilities that are considered financial instruments. Carrying
values were assumed to approximate fair values for these financial instruments as they are short-term in nature and
their recorded amounts approximate fair values or are receivable or payable on demand.

Note 37 - Financial risk management

The Company''s board of directors has overall responsibility for the establishment and oversight of the Company''s risk
management framework. The major risk to which the company is exposed are described below:

A. Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instruments
fail to meet its contractual obligations. The Company is exposed mainly to credit risk arises from cash and cash
equivalents, deposit with banks and outstanding trade receivables.

(a) Trade Receivables

The Company extends credit to customers in normal course of business. The Company considers factor such
as credit report of customer, industry practice, payment record etc. The Company evaluates the concentration
of risk with respect to trade receivables and unbilled revenue as low. The exposure of trade receivables and the
expected credit loss measured on the same using simplified approach is as following.

(b) Cash and cash equivalent and Bank deposits

The Company considers factors such as track record, size of institution, market reputation, credit institution with
high credit ratings and service standards to select the banks with which balances and deposits are maintained.
The balance and fixed deposits are generally maintained with the banks with whom the Company has availed the
credit facilities. Further the Company does not maintain significant cash in hand other than those required for its
day to day operations. Considering the same, the Company is not exposed to expected credit loss of cash and
cash equivalent and bank deposits.

B. Liquidity risk

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with
its financial liabilities that are settled by delivering cash or another financial asset. The Company''s approach
to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities
when they are due, under both normal and stressed conditions, without incurring unacceptable losses or risking
damage to the Company''s reputation.

Maturity Pattern

The following are the remaining contractual maturities of financial liabilities at the reporting date. The amounts
are gross and undiscounted.

C. Price risk

The company is not exposed to price risk.

D. Interest rate risk

The company is not exposed to interest rate risk.

Note 38 - Employee stock option scheme

a) Employee stock option scheme (equity settled)

The Company has established the following Employee Stock Option Plans, as approved by the shareholders at
various Extra-Ordinary General Meetings (EGMs):

i) ESOP 2019: Approved at the EGM held on June 06, 2019, comprising a pool of 2,56,985 options.

ii) ESOP 2021: Approved at the EGM held on July 23, 2021, comprising a pool of 1,50,000 options.

iii) ESOP 2022: Approved at the EGM held on June 23, 2022, with an initial pool of 9,47,206 options, which was
subsequently increased by 1,00,000 options pursuant to shareholder approval at the EGM held on January
27, 2025, aggregating to 10,47,206 options.

Each of the above Plans authorises the Company to grant stock options to eligible employees in one or more
tranches, on such terms and conditions as determined under the respective schemes.

During the current year, the company has granted 4,45,813 (Previous year : 2,78,860) equity shares as ESOP
to eligible employees as per ESOP Plan. Employee compensation cost has been accounted at fair value of the
options as at grant date. 1,23,670 options has been exercised during the current year.

c) Fair value of options granted

The fair value at grant date is determined using the Black Scholes Model which takes into account the exercise
price, the term of the option, the share price at grant date and expected price volatility of the underlying share,
the expected dividend yield and the risk free interest rate for the term of the option.

The options granted for no consideration and will vest upon the completion of service condition as specified in
scheme in graded manner. Vested options are exercisable for the period of five years after the vesting.

Note 40 - Segment reporting

The Company operates in a single business segment. There are no other separate reportable segments. Hence,
no disclosures related to segments is required to be given under the Indian Accounting Standard 108 (Ind AS 108)
"Segment Reporting".

The company has identified customers that individually contributes 10% or more of its total revenue from external
customers. During the year ended 31^st March 2026, revenue from three such customers amounted to ?1,936.42
million, ?1,711.53 million and ?1,570.49 million respectively. These revenues were reported under sourcing &
servicing fees and other fees & charges.

Note 41 - Foreign exchange earnings/outflow

i) The foreign exchange earnings is Nil for the year ended 31 March 2026 (Previous year : ?Nil)

ii) The foreign exchange outflow is ?93.69 million for the year ended 31 March 2026 (Previous year : ?76.67 million)

Note 42 - Others

i) The Company did not have any transactions with companies struck off under Section 248 of the Companies Act,
2013 or Section 560 of Companies Act, 1956 during the financial year.

ii) The Company do not have any Benami property, where any proceeding has been initiated or pending against the
Company for holding any Benami property.

iii) The Company has not been declared as a wilful defaulter by any lender who has powers to declare a company as
a wilful defaulter at any time during the financial year or after the end of reporting year but before the date when the
financial statements are approved.

iv) The Company do not have any cases where quarterly returns or statements of current assets filed by the Company
with banks or financial institutions are not in agreement with the books of accounts.

v) The Company do not have any charges or satisfaction which is yet to be registered with Registrar of Companies
beyond the statutory year.

vi) The Company have not traded or invested in Crypto currency or Virtual Currency during the financial year.

vii) During the year no scheme of arrangement have been approved by competent authority.

viii) The Company does not have transaction which is not recorded in the books of accounts that has been surrendered
or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or
survey or any other relevant provisions of the Income Tax Act, 1961).

ix) The Company have not advanced or loan or invested funds to any other person(s) or entity(ies), including foreign
entities (Intermediaries) with the understanding that the Intermediary shall:

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Company (Ultimate Beneficiaries), or

(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

x) The Company have not received any fund from any person(s) or entity(ies), including foreign entities (Funding
Party) with the understanding (whether recorded in writing or otherwise) that the Company shall :

(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on
behalf of the Funding Party (Ultimate Beneficiaries) or

(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries,

xi) The Company has one subsidiary and complied with the number of layers prescribed under clause (87) of section
2 of the Act read with the Companies (Restriction on number of Layers) Rules, 2017.

xii) The Company did not have any borrowings from banks/financial institutions and accordingly disclosure
prescribed in amended Schedule III are not applicable.

xiii) The Company does not have any immovable property.

xiv) The Company has not revalued its property, plant and equipment (including right-of-use assets) or intangible
assets or both during the year.

Note 43 - Comparative figures

Previous year figures have been regrouped and reclassified, wherever considered necessary, to conform to the
current year presentation, to the extent applicable.

Note 44 - Events after the reporting date

Subsequent to the year ended 31 March 2026, the Company completed its initial public offering ("IPO") of 54,147,390
equity shares of face value of ?1 each at an issue price of ?171 per share, comprising fresh issue of 49,707,602 equity
shares and offer for sale of 44,39,788 equity shares. Pursuant to the IPO, the equity shares were listed on National
Stock Exchange of lndia Limited and BSE Limited on May 08, 2026. Pursuant to the said allotment, the paid-up equity
share capital of the Company has increased from ?118.78 million to ?168.48 million comprising 16,84,83,022 fully
paid-up equity shares of ?1 each on May 8, 2026.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article